Clinical Trial Update: QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of the NANT Urothelial Cancer Vaccine for urothelial carcinoma in patients who progressed after chemotherapy and PD-1/PD-L1 therapy has been w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• NANT Urothelial Cancer Vaccine (NANT urothelial cancer vaccine)

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Urothelial Carcinoma | Phase 1, Phase 2 | Status: WITHDRAWN